Hero image

Deepak Khanna

Interim leader, Human Health International

Deepak Khanna is interim leader, Human Health International, heading operations, commercialization and P&L performance for MSD’s 100-plus markets outside of the U.S. He also serves as president, Europe & Canada, responsible for the company’s Human Health business across the region. 

Deepak began his MSD career in 1988 in field sales and over his tenure, has held positions of increasing responsibility within the Global, U.S. and international Human Health divisions. In his more than 30 years with the company, Deepak has gained broad and deep expertise in managing country and regional operations as well as building and leading diverse, high-performing teams. He has also headed strategy and commercialization efforts for several therapeutic areas, including Oncology. In addition, Deepak proudly spearheaded U.S. integration planning for the company’s merger with Schering-Plough.

Deepak earned his bachelor’s degree in biochemistry and economics from the University of California, Berkeley, and an MBA in marketing from Santa Clara University.

Hero image

Jannie Oosthuizen

President, MSD Human Health U.S.

Jannie Oosthuizen leads MSD Human Health U.S., which is MSD’s largest business globally. He is responsible for P&L, strategy, customer engagement and commercialization in the U.S. for MSD’s broad portfolio of human health medicines and vaccines.

Jannie joined the company in 2014 to lead the Human Health oncology business in Asia Pacific and Latin America, then led MSD’s business in Japan from 2016 to 2020, and then led Global Marketing for Oncology. In each of these roles, Jannie successfully created and implemented new strategies and innovative commercial models that delivered strong, leveraged growth and established MSD as a leading business in those markets and therapeutic areas.

Jannie has deep experience in a broad range of global markets and therapeutic areas, and in building and leading high-performing teams. Prior to MSD, Jannie spent 20 years at Eli Lilly in a wide range of commercial and marketing roles with increasing responsibility. He began his career with Eli Lilly in 1993 in his home country of South Africa. Jannie is a pharmacist by training and graduated from North-West University in South Africa. He has lived and worked in six countries spanning five continents with his wife and three children.

Hero image

Cristal N. Downing

Executive vice president and chief communications & public affairs officer

Cristal Downing joined MSD as executive vice president and chief communications & public affairs officer in 2021. In this role, Cristal leads MSD’s Corporate Affairs organization and is responsible for the development, advancement and execution of the company’s communications, public affairs, and Environmental, Social and Governance (ESG) efforts. Guided by business priorities and dedication to all who depend on the company’s lifesaving and life-changing work, Cristal is focused on fostering a deep understanding of MSD’s scientific contributions and impact on global health, ensuring public policy priorities stay aligned with business priorities, and enabling strategic engagement and impactful outcomes with a broad range of internal and external stakeholders.  

Most recently, Cristal was vice president, Communications & Public Affairs, Medical Devices, at Johnson & Johnson, where she fortified and amplified the strategy that conveys how the business is elevating the standard of patient care. Prior to that, she held the role of vice president, Global Finance Communications at Johnson & Johnson, where she partnered with the chief financial officer to implement communications and public affairs strategies that enabled the CFO and CEO strategic platforms.

Cristal also co-led the development and implementation of “Our Race to Health Equity” — Johnson & Johnson’s Racial & Social Justice strategy. She has more than 20 years of leadership expertise and capabilities, working in dynamic and complex organizations, including American Express, JP Morgan Chase, and Wells Fargo.

Cristal is a member of the board of trustees for the Ronald McDonald House of Central & Northern New Jersey and is affiliated with several key communications associations. Cristal received her bachelor of arts degree in communications from Monmouth University.

Hero image

Michael A. Klobuchar

Executive vice president and chief strategy officer

Mike Klobuchar serves as the chief strategy officer for MSD. He leads the advancement and execution of the company’s strategy, with additional responsibility for business development and information technology. Prior to this role, Mike was senior vice president and finance lead for MSD Research Laboratories, the company’s research and development organization, and led the Global Portfolio and Alliance Management group within the organization.

Previously, Mike was senior vice president, Corporate Strategy and Financial Planning, focused on developing and implementing improvements to the company’s operating model. He was also president, MSD Global Health Innovation Fund, and led key elements related to the integration of MSD Research Laboratories with Schering-Plough R&D following the merger of the two companies.

Mike joined MSD Research Laboratories in 1998 and has held a wide range of positions of increasing responsibility in the company’s finance, strategy, manufacturing and research organizations.

Mike received his MBA from Villanova University, a master of science degree in chemical engineering from Rutgers University and a bachelor of science degree from Purdue University.

Hero image

Caroline Litchfield

Executive vice president and chief financial officer

Caroline Litchfield is executive vice president and chief financial officer for MSD, responsible for the company’s finance, procurement and real estate operations. 

Prior to this role, Caroline served as the company’s treasurer, a position that included responsibility for treasury, tax and investor relations. From 2014 to 2018, Caroline led finance for Human Health, the company’s largest business, overseeing financial operations and reporting in approximately 100 markets.

Previously, Caroline was the vice president and finance lead for the company’s Emerging Markets region when it was established in 2009 following the merger of MSD and Schering-Plough and was instrumental in integrating the two companies. She joined MSD in 1990 in its U.K. business and has held a wide range of positions of increasing responsibility in the company’s country, regional and global finance functions.

Caroline received her Bachelor of Science degree in Mathematics from the University of Leicester and is a fellow of the Chartered Institute of Management Accountants.

Hero image

Stephen L. Mayo, Ph.D.

Director since
2021

Committees
Audit
Research

Download bio

Download photo

Experience

Dr. Mayo has extensive scientific experience relevant to the biopharmaceutical industry, including being the Bren Professor of Biology and Chemistry and former Chair of the Division of Biology and Biological Engineering at the California Institute of Technology (“Caltech”) and co-founder of Xencor, a public antibody engineering company. In addition, in his role as the former Vice Provost at Caltech, Dr. Mayo oversaw Caltech’s technology licensing program. Elected to the National Academy of Sciences in 2004 for his pioneering contributions in the field of protein design, Dr. Mayo has also served as a presidential appointee on the National Science Foundation’s National Science Board and as an elected board member for the American Association for the Advancement of Science.

Career highlights

California Institute of Technology

  • Bren Professor of Biology and Chemistry (2007–present)
  • Chair, Division of Biology and Biological Engineering (2010–2020)
  • Vice Provost for Research (2007–2010)

Howard Hughes Medical Institute, non-profit medical research organization

  • Investigator (1994–2007)
Hero image

Dean Y. Li, M.D., Ph.D.

Executive vice president and president, MSD Research Laboratories

Dean Li serves as executive vice president and president of MSD Research Laboratories. He leads the company’s worldwide human vaccines and therapeutics research and development organization.

Since joining MSD in 2017 Dean has held leadership roles in the Translational Medicine and Discovery functions and was appointed to President, MSD Research Laboratories in January 2021.

Prior to joining MSD, Dean held positions of increasing responsibility in translational medical research at the University of Utah. Most recently he served as the H.A. & Edna Benning Professor of Medicine and Cardiology, chief scientific officer, associate vice president and vice dean at the University of Utah Health System. From 2015 to 2016, he also served as interim CEO of Associated Regional University Pathologists, one of the United States’ largest clinical reference laboratories. During his tenure at the University of Utah, he co-founded several biotechnology companies based upon research conducted in his laboratory, including Recursion Pharmaceuticals, Hydra Biosciences and Navigen Pharmaceuticals.    

Dean received his Bachelor’s degree in Chemistry from the University of Chicago and his graduate and clinical training at Washington University School of Medicine in St. Louis. Dean is a board-certified cardiologist, a member of the American Society for Clinical Investigation and the Association of American Physicians.

Hero image

Dave Williams

Executive vice president, chief information & digital officer

Dave Williams is MSD’s chief information and digital officer. Under his direction the technology organization is focused on helping MSD’s research, manufacturing and business units develop and leverage digital solutions to serve customers and achieve business value.

Previously, Dave was chief information officer of MSD Animal Health. There he led the development and execution of a digital transformation that deployed several cloud-based platforms and capabilities, resulting in streamlined operations and improved customer engagement.

Prior to that, Dave founded MSD Animal Health Ventures, which brings together capabilities across veterinarians, start-ups, inventors, entrepreneurs, customers and investment partners to develop new solutions that address unmet customer needs. He also led Sure Petcare, a companion-animal portfolio of digital services and solutions within MSD Animal Health, where he had profit-and-loss responsibility.

Earlier in his career, Dave was executive director of enterprise information management at MSD and held several IT leadership roles at Schering-Plough.

Dave currently serves on the board of the National Center for Women in Technology and is a member of the Osage Partners Advisory Council.

He holds a bachelor of science in economics and finance from the University of Scranton.

Hero image

Risa J. Lavizzo-Mourey, M.D.

Director since
2020

Committees
Compensation & Management Development
Governance

Download bio

Download photo

Experience

Dr. Lavizzo-Mourey has extensive health policy experience, serving as the PIK Professor of Health Equity and Health Policy and formerly as President and Chief Executive Officer of Robert Wood Johnson Foundation, the nation’s largest healthcare-focused philanthropic organization. Her role at Robert Wood Johnson Foundation provided her with deep management, strategic, human capital and talent development expertise. In addition, her directorships at other public companies, including her service as Chair of the Governance Committee at GE, provide her with extensive experience on corporate governance matters. Dr. Lavizzo-Mourey was elected to the National Academy of Medicine, American Academy of Arts and Sciences and The American Philosophical Society.

Career highlights

University of Pennsylvania

  • Penn Integrates Knowledge Professor of Health Equity and Health Policy (2018-present)

Robert Wood Johnson Foundation

  • President Emerita (2017-present)
  • President and Chief Executive Officer (2003-2017)
  • Senior Vice President and Director (2001-2002)
Hero image

Peter C. Wendell

Director since
2003

Committees
Compensation & Management Development
Research

Download bio

Download photo

Experience

Mr. Wendell has extensive management, financial and venture capital expertise as demonstrated by his positions as a managing director of Sierra Ventures, his service as a board member and senior advisor at WestBridge Capital, his status as a lecturer in strategic management at the Stanford University Graduate School of Business for over 20 years, and his former chairmanship of the Princeton University endowment.

Career highlights

Sierra Ventures, technology-oriented venture capital firm

  • Managing director (1982-present)

Stanford University

  • Faculty, Stanford University Graduate School of Business (1991-present)